Skip to content
Skip to main navigation
Skip to 1st column
Skip to 2nd column
212.612.3030
Home
About Us
Our History
Our Experience
Medical and Commercial Knowledge
Analysis, Insight and Perspective
Process Management
Communication and Presentation
Scisive Disorder Map
Scisive Market Landscape
Our People
Founders
Bob Easton
Mary Koto
Frank Russo
Catharine Staughton
Staff Consultants
Careers
Our Network
Our Clients
Our Services
Types of Engagement
Sample Projects
Recent Assignments
News and Conferences
News
Conferences
Publications
Contact
Contact Info
Careers
Autism Survey
Site Map
Home
About Us
Our History
Our Experience
Medical and Commercial Knowledge
Analysis, Insight and Perspective
Process Management
Communication and Presentation
Scisive Disorder Map
Scisive Market Landscape
Our People
Founders
Bob Easton
Mary Koto
Frank Russo
Catharine Staughton
Staff Consultants
Careers
Our Network
Our Clients
Our Services
Types of Engagement
Sample Projects
Recent Assignments
News and Conferences
News
Bob Easton Re-elected to Cepheid Board
Francis J. Russo Reelected Director of NCMIC Group, Inc.
Apex Bioventures to seek shareholder approval to liquidate
Robert Easton appointed to NYBA Board of Directors
Conferences
Robert J. Easton to Moderate Panel on In Vitro Diagnostics
Robert J. Easton to Serve as Panelist at the NYBA 20th Annual Meeting
Scisive Moderates Session on Top 10 Most Partnerable Drug Candidates
Robert J. Easton to Moderate Panel on the Strategic Rationale Behind Three of the Most Strategically Interesting Deals of the Year
Robert J. Easton To Moderate Panel on New Business Models for In Vitro Diagnostics
Robert J. Easton Speaks on Evolution of the Pharma Industry
Robert J. Easton Speaks on the Medical Industry in India
Robert J. Easton Moderates Panel on Drug Life Cycle Management
Scisive to Present at the CalAsia Meeting
Scisive to present at BIO International 2009 Convention
Scisive to present at NYBA 18th Annual Meeting
Publications
New Investment Opportunities in Diagnostics
Matchmaking in Drug Partnering: Identifying the Right Drugs and the Right Partners
New Business Models for In Vitro Diagnostics
Natural Selection in the Pharma Industry: Biotech vs. Big Pharma – Who Eats Whom?
Big Pharma, the Polar Bear, and the Need to Specialize
Biotech M&A - How to Sell Your Company in an Environment of Consolidation
Paying (and Not Paying) for Expensive New Therapies
Valuing Partnering Agreements
Contact
Contact Info
Careers
Autism Survey